Covered recipient · General Payments record
MARWA MOHAMMED SABHA
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2022–2024
$2,288.47
- Reported across 111 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $809.09 | 36 |
| Education | $99.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $286.16 | 20 |
| Amgen Inc. | $236.12 | 4 |
| Janssen Biotech, Inc. | $174.94 | 4 |
| UCB, Inc. | $67.01 | 3 |
| Lilly USA, LLC | $58.80 | 2 |
| PFIZER INC. | $28.82 | 1 |
| Alexion Pharmaceuticals, Inc. | $21.49 | 1 |
| GlaxoSmithKline, LLC. | $20.44 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $14.31 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (37)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.33 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105994997 | CMS |
| ABBVIE INC. | $25.79 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105994999 | CMS |
| ABBVIE INC. | $6.18 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105995001 | CMS |
| ABBVIE INC. | $7.66 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105995003 | CMS |
| ABBVIE INC. | $31.59 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105995005 | CMS |
| ABBVIE INC. | $5.98 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105995007 | CMS |
| ABBVIE INC. | $7.50 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105995009 | CMS |
| ABBVIE INC. | $7.86 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105995011 | CMS |
| ABBVIE INC. | $1.78 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105995013 | CMS |
| ABBVIE INC. | $2.61 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105995015 | CMS |
| ABBVIE INC. | $20.93 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105995017 | CMS |
| ABBVIE INC. | $22.43 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105995019 | CMS |
| ABBVIE INC. | $2.14 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105995021 | CMS |
| ABBVIE INC. | $22.15 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105995023 | CMS |
| ABBVIE INC. | $1.74 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105995025 | CMS |
| ABBVIE INC. | $26.88 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105995027 | CMS |
| ABBVIE INC. | $16.61 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105995029 | CMS |
| ABBVIE INC. | $5.26 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105995031 | CMS |
| ABBVIE INC. | $23.44 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105995033 | CMS |
| ABBVIE INC. | $29.30 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105995035 | CMS |
| Alexion Pharmaceuticals, Inc. | $21.49 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093895221 | CMS |
| Amgen Inc. | $28.75 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111694740 | CMS |
| Amgen Inc. | $30.30 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111694738 | CMS |
| Amgen Inc. | $28.11 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117371793 | CMS |
| Amgen Inc. | $148.96 | 11/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117371795 | CMS |
| GlaxoSmithKline, LLC. | $20.44 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116253417 | CMS |
| Janssen Biotech, Inc. | $30.18 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078707829 | CMS |
| Janssen Biotech, Inc. | $18.21 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078709975 | CMS |
| Janssen Biotech, Inc. | $99.00 | 09/19/2024 | Education | Undisputed | 01/23/2026 | 1078709611 | CMS |
| Janssen Biotech, Inc. | $27.55 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078708775 | CMS |
| Lilly USA, LLC | $30.15 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135199288 | CMS |
| Lilly USA, LLC | $28.65 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135180219 | CMS |
| Novartis Pharmaceuticals Corporation | $14.31 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087301963 | CMS |
| PFIZER INC. | $28.82 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130890603 | CMS |
| UCB, Inc. | $18.10 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143106426 | CMS |
| UCB, Inc. | $19.43 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143106428 | CMS |
| UCB, Inc. | $29.48 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143106430 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.